Discontinuation of oral antivirals in chronic hepatitis B: A systematic review

2016275 citationsReview

Authors

George Papatheodoridis · Laiko General Hospital of Athens

Jiannis Vlachogiannakos · Laiko General Hospital of Athens

Εvangelos Cholongitas · Ippokrateio General Hospital of Thessaloniki

Karsten Wursthorn · Universität Hamburg

Christos Thomadakis · National and Kapodistrian University of Athens

Giota Touloumi · National and Kapodistrian University of Athens

Jörg Petersen

Abstract

Durable VR seems to be feasible in a substantial proportion of patients who discontinue long-term NA therapy; on-therapy VR > 24 months offers higher chances of off-NA VR in patients with HBeAg-negative chronic hepatitis B.

Topics & Keywords

Hepatitis B Virus Studies Hepatitis C virus research Liver Disease Diagnosis and Treatment

Publication Details

Published in: Hepatology

Volume 63, Issue 5, pp. 1481-1492

DOI: 10.1002/hep.28438

Field-Weighted Citation Impact: 24.79

Command Palette

Discontinuation of oral antivirals in chronic hepatitis B: A systematic review

Authors

Abstract

Topics & Keywords

Publication Details